Dilaudid and Urethral pain - a phase IV clinical study of FDA data

Summary:

Urethral pain is reported as a side effect among people who take Dilaudid (hydromorphone hydrochloride), especially for people who are 50-59 old, have been taking the drug for < 1 month also take Plavix, and have Metastases to bone.

The phase IV clinical study analyzes which people have Urethral pain when taking Dilaudid. It is created by eHealthMe based on reports of 95,518 people who have side effects when taking Dilaudid from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Urethral pain?

Urethral pain is found to be associated with 88 drugs and 280 conditions by eHealthMe. Check the latest studies of Urethral pain.

On Jul, 27, 2026

95,518 people reported to have side effects when taking Dilaudid.
Among them, 15 people (0.02%) have Urethral pain.

Among these 15 people:

How long have people been on Dilaudid when they have Urethral pain? *

What is the age of people who have Urethral pain when taking Dilaudid? *

What are other drugs people take besides Dilaudid? *

What are other side effects people have besides Urethral pain? *

Hyperhidrosis (abnormally increased sweating): 11 people, 73.33%
Nausea (feeling of having an urge to vomit): 11 people, 73.33%
Weakness: 10 people, 66.67%
Hepatic Steatosis (fatty liver disease): 9 people, 60.00%
Atherosclerosis (disorder of the arteries): 9 people, 60.00%
Infection: 9 people, 60.00%
Blood Glucose Increased: 9 people, 60.00%
Pulmonary Congestion (congestion in the lungs): 9 people, 60.00%
Prostatic Specific Antigen Increased: 9 people, 60.00%
Coronary Artery Stenosis (narrowing of coronary artery): 9 people, 60.00%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 9 people, 60.00%
Blood Pressure Abnormal: 2 people, 13.33%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 13.33%
Neuroendocrine Tumor: 2 people, 13.33%
Joint Pain: 2 people, 13.33%
Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract): 1 person, 6.67%
Gravitational Oedema (abnormally large fluid volume in the circulatory system makes obese): 1 person, 6.67%
Breakthrough Pain: 1 person, 6.67%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 1 person, 6.67%
Calculus Ureteric (stone in ureter): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and have Urethral pain?

- Check whether Urethral pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dilaudid:

Dilaudid (96,466 reports)

Urethral pain treatments and more:

Urethral pain (747 reports)

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urethral pain:

Urethral pain (88 drugs)

Browse all the conditions that are associated with Urethral pain:

Urethral pain (280 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydromorphone hydrochloride (the active ingredients of Dilaudid) and Dilaudid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.